+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Biological Valve Market - Global Forecast 2026-2032- Product Image
Artificial Biological Valve Market - Global Forecast 2026-2032- Product Image
Sale

Artificial Biological Valve Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6116933
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Artificial Biological Valve Market is projected to reach USD 8.72 Billion in 2026. It is expected to continue growing at a CAGR of 5.32%, reaching USD 11.93 Billion by 2032.

Artificial Biological Valves: Executive Overview

Artificial biological valves are tissue-based replacement devices designed to restore cardiac blood flow when native valves are diseased or damaged. Their clinical value is tied to hemodynamic performance, durability, thrombogenicity, implantation technique, and the patient’s age, anatomy, comorbidities, and treatment preferences. Decision-making increasingly weighs surgical replacement against transcatheter approaches, while long-term follow-up remains essential for assessing structural valve deterioration and complications.

Clinical Practice Is Shifting Toward Personalized Valve Selection

The artificial biological valve landscape is being reshaped by broader use of minimally invasive and transcatheter procedures, improvements in imaging, and greater attention to lifetime management. Clinicians increasingly evaluate valve choice through a multidisciplinary process that considers durability, anticoagulation requirements, reintervention options, anatomical suitability, and procedural risk. Regulatory scrutiny, evidence requirements, implantability, and post-market surveillance also remain central to adoption and patient safety.

Artificial Intelligence Strengthens Diagnosis, Planning, and Follow-Up

Artificial intelligence is contributing to the interpretation of echocardiography and other cardiovascular images, helping identify valve dysfunction, quantify disease severity, and support procedural planning. Data-driven tools may also assist patient selection, predict complications, optimize follow-up intervals, and detect early signs of structural deterioration. Their effective use depends on representative clinical datasets, transparent validation, cybersecurity, clinician oversight, and integration with existing hospital workflows; AI should support rather than replace specialist judgment.

Regional Differences Reflect Access, Infrastructure, and Clinical Practice

North America combines advanced imaging, specialized valve centers, and established transcatheter pathways, while Latin America presents varied access to cardiac surgery, diagnostics, reimbursement, and follow-up services. Europe benefits from coordinated clinical guidance and mature specialist networks, although access differs among health systems. The Middle East is expanding advanced cardiovascular capacity unevenly, and Africa continues to face constraints involving specialist availability, referral systems, diagnostics, and continuity of care. Asia-Pacific contains highly developed markets alongside rapidly expanding systems, creating substantial variation in procedural access, local expertise, and device procurement.

Economic Blocs Influence Regulation, Procurement, and Care Pathways

ASEAN markets are shaped by differing regulatory systems, healthcare resources, and cross-border referral patterns. BRICS members show wide variation in manufacturing capability, public-sector capacity, affordability, and access to specialist cardiac services. The European Union benefits from shared regulatory structures but retains national differences in reimbursement and hospital organization. G7 systems generally have strong clinical infrastructure, although aging populations and budget pressures affect service delivery. GCC countries are investing in advanced cardiovascular centers, while NATO members span diverse healthcare models and procurement environments, making harmonized clinical evidence and training valuable across the groupings.

Country-Level Priorities Vary Across Established and Developing Systems

Australia emphasizes specialist cardiac services, evidence-based selection, and management across geographically dispersed populations. Brazil and Mexico face the dual challenge of expanding access while addressing regional differences in diagnosis, surgery, reimbursement, and follow-up. Canada and the United States have advanced valve programs but must manage capacity, affordability, and equitable access. China and India are broadening cardiovascular infrastructure while navigating population scale and regional disparities. France, Germany, Italy, Spain, and the United Kingdom continue to refine multidisciplinary pathways, transcatheter integration, and long-term surveillance. Japan and South Korea combine sophisticated clinical systems with strong emphasis on imaging, procedural quality, and demographic aging. Russia’s access and procurement environment remains influenced by health-system capacity, geography, and international supply conditions.

Prioritize Lifetime Management, Evidence Quality, and Service Readiness

Industry leaders should align product development with lifetime patient management rather than single-procedure performance. Priorities include robust durability evidence, clear patient-selection criteria, compatibility with future interventions, streamlined implantation, and reliable follow-up tools. Organizations should build partnerships with valve centers, invest in clinician training and imaging capability, support registries with meaningful outcomes, and design access strategies suited to local reimbursement and infrastructure. AI initiatives should use clinically validated endpoints, strong governance, and human review. Procurement and commercialization plans should also account for supply resilience, post-market monitoring, and equitable access.

Methodology: Evidence-Based Synthesis of Clinical and System Factors

This executive summary uses a structured qualitative synthesis focused on artificial biological valves. The assessment considers clinical indications, device attributes, procedural evolution, imaging, artificial intelligence, regulation, reimbursement, healthcare infrastructure, workforce requirements, and regional variation. Insights are framed without market estimates, market sizing, market shares, forecasts, or company-specific claims. Interpretation should be supplemented with current clinical guidelines, peer-reviewed evidence, regulatory documentation, health-technology assessments, and local procurement and reimbursement policies.

Long-Term Value Depends on Integrated Valve Care

Artificial biological valves occupy an important role in contemporary management of valvular heart disease, particularly where reduced long-term anticoagulation burden and tissue-based performance are clinically relevant. Progress will depend not only on device design but also on accurate diagnosis, appropriate patient selection, skilled implantation, durable evidence, equitable access, and lifelong surveillance. The strongest health-system strategies will connect innovation with multidisciplinary care, validated digital tools, and regionally appropriate implementation.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Artificial Biological Valve Market, by Tissue Material
7.1. Introduction
7.2. Homograft
7.2.1. Cryopreserved
7.2.2. Decellularized
7.3. Xenograft
7.3.1. Bovine
7.3.2. Porcine
8. Artificial Biological Valve Market, by Implantation Method
8.1. Introduction
8.2. Surgical
8.2.1. Minimally Invasive
8.2.2. Open Replacement
8.3. Transcatheter
8.3.1. Transaortic
8.3.2. Transapical
8.3.3. Transfemoral
9. Artificial Biological Valve Market, by Valve Position
9.1. Introduction
9.2. Aortic
9.3. Mitral
9.4. Pulmonary
9.5. Tricuspid
10. Artificial Biological Valve Market, by End User
10.1. Introduction
10.2. Ambulatory Surgery Centers
10.3. Hospitals
10.4. Specialized Clinics
11. Artificial Biological Valve Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Artificial Biological Valve Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Artificial Biological Valve Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Artivion, Inc.
15.3. Boston Scientific Corporation
15.4. Braile Biomédica
15.5. Colibri Heart Valve
15.6. Corcym
15.7. Edwards Lifesciences
15.8. Foldax, Inc.
15.9. Jenavalve Technology, Inc.
15.10. Labcor Laboratórios Ltda
15.11. Lepu Medical Technology Co., Ltd.
15.12. LifeNet Health
15.13. LivaNova PLC
15.14. Medtronic plc
15.15. TTK Healthcare Limited
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Artificial Biological Valve Market, Years Considered for the Study
FIGURE 2. Global Artificial Biological Valve Market, Research Design
FIGURE 3. Global Artificial Biological Valve Market, Research Framework
FIGURE 4. Global Artificial Biological Valve Market, Data Triangulation
FIGURE 5. Global Artificial Biological Valve Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Artificial Biological Valve Market Size, by Tissue Material, 2025 vs 2032 (%)
FIGURE 7. Global Artificial Biological Valve Market Size, by Tissue Material, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Artificial Biological Valve Market Size, by Implantation Method, 2025 vs 2032 (%)
FIGURE 9. Global Artificial Biological Valve Market Size, by Implantation Method, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Artificial Biological Valve Market Size, by Valve Position, 2025 vs 2032 (%)
FIGURE 11. Global Artificial Biological Valve Market Size, by Valve Position, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Artificial Biological Valve Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Artificial Biological Valve Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Artificial Biological Valve Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Artificial Biological Valve Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Artificial Biological Valve Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Artificial Biological Valve Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Artificial Biological Valve Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Artificial Biological Valve Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Artificial Biological Valve Market Segmentation & Coverage
TABLE 2. Global Artificial Biological Valve Market Size, 2017-2032 (USD Million)
TABLE 3. Global Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 4. Global Homograft Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Homograft Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Homograft Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Cryopreserved Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Cryopreserved Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Cryopreserved Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Decellularized Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Decellularized Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Decellularized Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Xenograft Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Xenograft Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Xenograft Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Bovine Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Bovine Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Bovine Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Porcine Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Porcine Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Porcine Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 23. Global Surgical Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Surgical Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Surgical Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Minimally Invasive Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Minimally Invasive Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Minimally Invasive Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Open Replacement Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Open Replacement Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Open Replacement Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Transcatheter Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Transcatheter Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Transcatheter Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Transaortic Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Transaortic Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Transaortic Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Transapical Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Transapical Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Transapical Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Transfemoral Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Transfemoral Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Transfemoral Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 45. Global Aortic Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Aortic Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Aortic Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Mitral Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Mitral Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Mitral Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Pulmonary Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Pulmonary Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Pulmonary Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Tricuspid Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Tricuspid Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Tricuspid Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 58. Global Ambulatory Surgery Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Ambulatory Surgery Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Ambulatory Surgery Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Specialized Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Specialized Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Specialized Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Artificial Biological Valve Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Artificial Biological Valve Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. North America Artificial Biological Valve Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. North America Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 79. North America Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 80. North America Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 81. North America Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 82. North America Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 83. North America Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 84. North America Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 85. North America Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 86. Latin America Artificial Biological Valve Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Latin America Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 88. Latin America Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 89. Latin America Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 90. Latin America Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 91. Latin America Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 92. Latin America Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 93. Latin America Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 94. Latin America Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. Europe Artificial Biological Valve Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Europe Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 97. Europe Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 98. Europe Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 99. Europe Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 100. Europe Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 101. Europe Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 102. Europe Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 103. Europe Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Middle East Artificial Biological Valve Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Middle East Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 106. Middle East Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 107. Middle East Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 108. Middle East Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 109. Middle East Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 110. Middle East Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 111. Middle East Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 112. Middle East Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. Africa Artificial Biological Valve Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Africa Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 115. Africa Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 116. Africa Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 117. Africa Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 118. Africa Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 119. Africa Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 120. Africa Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 121. Africa Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. Global Artificial Biological Valve Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. ASEAN Artificial Biological Valve Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. ASEAN Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 125. ASEAN Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 126. ASEAN Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 127. ASEAN Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 128. ASEAN Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 129. ASEAN Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 130. ASEAN Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 131. ASEAN Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. GCC Artificial Biological Valve Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. GCC Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 134. GCC Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 135. GCC Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 136. GCC Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 137. GCC Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 138. GCC Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 139. GCC Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 140. GCC Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. European Union Artificial Biological Valve Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. European Union Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 143. European Union Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 144. European Union Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 145. European Union Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 146. European Union Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 147. European Union Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 148. European Union Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 149. European Union Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. BRICS Artificial Biological Valve Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. BRICS Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 152. BRICS Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 153. BRICS Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 154. BRICS Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 155. BRICS Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 156. BRICS Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 157. BRICS Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 158. BRICS Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. G7 Artificial Biological Valve Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. G7 Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 161. G7 Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 162. G7 Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 163. G7 Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 164. G7 Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 165. G7 Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 166. G7 Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 167. G7 Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 168. NATO Artificial Biological Valve Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. NATO Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 170. NATO Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 171. NATO Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 172. NATO Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 173. NATO Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 174. NATO Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 175. NATO Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 176. NATO Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. Global Artificial Biological Valve Market Size, by Country, 2017-2032 (USD Million)
TABLE 178. United States Artificial Biological Valve Market Size, 2017-2032 (USD Million)
TABLE 179. United States Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 180. United States Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 181. United States Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 182. United States Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 183. United States Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 184. United States Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 185. United States Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 186. United States Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. Canada Artificial Biological Valve Market Size, 2017-2032 (USD Million)
TABLE 188. Canada Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 189. Canada Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 190. Canada Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 191. Canada Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 192. Canada Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 193. Canada Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 194. Canada Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 195. Canada Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. Mexico Artificial Biological Valve Market Size, 2017-2032 (USD Million)
TABLE 197. Mexico Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 198. Mexico Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 199. Mexico Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 200. Mexico Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 201. Mexico Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 202. Mexico Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 203. Mexico Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 204. Mexico Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. Brazil Artificial Biological Valve Market Size, 2017-2032 (USD Million)
TABLE 206. Brazil Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 207. Brazil Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 208. Brazil Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 209. Brazil Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 210. Brazil Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 211. Brazil Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 212. Brazil Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 213. Brazil Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. United Kingdom Artificial Biological Valve Market Size, 2017-2032 (USD Million)
TABLE 215. United Kingdom Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 216. United Kingdom Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 217. United Kingdom Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 218. United Kingdom Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 219. United Kingdom Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 220. United Kingdom Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 221. United Kingdom Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 222. United Kingdom Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Germany Artificial Biological Valve Market Size, 2017-2032 (USD Million)
TABLE 224. Germany Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 225. Germany Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 226. Germany Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 227. Germany Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 228. Germany Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 229. Germany Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 230. Germany Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 231. Germany Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. France Artificial Biological Valve Market Size, 2017-2032 (USD Million)
TABLE 233. France Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 234. France Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 235. France Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 236. France Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 237. France Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 238. France Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 239. France Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 240. France Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. Russia Artificial Biological Valve Market Size, 2017-2032 (USD Million)
TABLE 242. Russia Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 243. Russia Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 244. Russia Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 245. Russia Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 246. Russia Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 247. Russia Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 248. Russia Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 249. Russia Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Italy Artificial Biological Valve Market Size, 2017-2032 (USD Million)
TABLE 251. Italy Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 252. Italy Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 253. Italy Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 254. Italy Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 255. Italy Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 256. Italy Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 257. Italy Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 258. Italy Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 259. Spain Artificial Biological Valve Market Size, 2017-2032 (USD Million)
TABLE 260. Spain Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 261. Spain Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 262. Spain Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 263. Spain Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 264. Spain Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 265. Spain Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 266. Spain Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 267. Spain Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 268. China Artificial Biological Valve Market Size, 2017-2032 (USD Million)
TABLE 269. China Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 270. China Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 271. China Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 272. China Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 273. China Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 274. China Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 275. China Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 276. China Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 277. India Artificial Biological Valve Market Size, 2017-2032 (USD Million)
TABLE 278. India Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 279. India Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 280. India Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 281. India Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 282. India Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 283. India Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 284. India Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 285. India Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. Japan Artificial Biological Valve Market Size, 2017-2032 (USD Million)
TABLE 287. Japan Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 288. Japan Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 289. Japan Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 290. Japan Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 291. Japan Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 292. Japan Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 293. Japan Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 294. Japan Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 295. Australia Artificial Biological Valve Market Size, 2017-2032 (USD Million)
TABLE 296. Australia Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 297. Australia Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 298. Australia Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 299. Australia Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 300. Australia Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 301. Australia Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 302. Australia Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 303. Australia Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 304. South Korea Artificial Biological Valve Market Size, 2017-2032 (USD Million)
TABLE 305. South Korea Artificial Biological Valve Market Size, by Tissue Material, 2017-2032 (USD Million)
TABLE 306. South Korea Artificial Biological Valve Market Size, by Homograft, 2017-2032 (USD Million)
TABLE 307. South Korea Artificial Biological Valve Market Size, by Xenograft, 2017-2032 (USD Million)
TABLE 308. South Korea Artificial Biological Valve Market Size, by Implantation Method, 2017-2032 (USD Million)
TABLE 309. South Korea Artificial Biological Valve Market Size, by Surgical, 2017-2032 (USD Million)
TABLE 310. South Korea Artificial Biological Valve Market Size, by Transcatheter, 2017-2032 (USD Million)
TABLE 311. South Korea Artificial Biological Valve Market Size, by Valve Position, 2017-2032 (USD Million)
TABLE 312. South Korea Artificial Biological Valve Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. Global Artificial Biological Valve Market Share, by Key Player, 2025
TABLE 314. Global Artificial Biological Valve Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Artivion, Inc.
  • Boston Scientific Corporation
  • Braile Biomédica
  • Colibri Heart Valve
  • Corcym
  • Edwards Lifesciences
  • Foldax, Inc.
  • Jenavalve Technology, Inc.
  • Labcor Laboratórios Ltda
  • Lepu Medical Technology Co., Ltd.
  • LifeNet Health
  • LivaNova PLC
  • Medtronic plc
  • TTK Healthcare Limited

Related Topics

Related Reports

Valves Market 2026-2030 - Product Image

Valves Market 2026-2030

  • Report
  • 316 Pages
  • Global
From
United States Valves - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

United States Valves - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 127 Pages
  • United States
From
North America Valves - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

North America Valves - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 100 Pages
  • North America
From
Valves - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Valves - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From
Artificial Pulmonary Valve System Market - Global Forecast 2026-2032 - Product Image

Artificial Pulmonary Valve System Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.